ANTI-CLAUDIN-5 Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Applications in which this antibody has been used successfully, and the associated peer-reviewed papers, are given below.
Immunocytochemistry (1 paper)

Allgemeine Beschreibung

The CLDN5 (claudins) gene is mapped to human chromosome 22q11.21 and codes for a transmembrane protein, which is a component of tight junction. The protein is a part of blood-brain barrier. The encoded protein is 303 - 218 amino acids long.

Biochem/physiol Actions

The CLDN5 (claudins) gene encodes a component of tight junction and serves as a selective barrier for solutes and water. Upregulation of CLDN5 was observed in migraine. The expression of CLDN5 is reduced in lung squamous carcinoma. CLDN5 is known to increase p21 and decrease cyclin D1, leading to the retardation of cell cycle G1 to S transition. Cldn5 maintains homeostasis of the central nervous system, being a part of blood-brain barrier.

ANTI-CLAUDIN-5 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

ANTI-CLAUDIN-5 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Shanghai Yubo Biotechnology Co., Ltd	021-60514606 18321282235	sale1@shybsw.net	China	8165	58
Merck Millipore	--	bioscience@merckgroup.com	China	6839	58
Merck KGaA	--	ordercn@merckgroup.com	China	6394	58
Aopeisai Biotechnology (Shanghai) Co., Ltd	13061929770	3004391297@qq.com	China	1780	58
shlmai	021-67680335 13052188602	sale1@shlmai.net	China	10000	58

---

• Anti-Claudin 5, C-Terminal antibody produced in rabbit
• ANTI-CLAUDIN-5
• Transmembrane protein deleted in VCFS
• CLD5
• CLDN5
• TMDVCF